Stem Cell Authority, Ltd. is a clinical-stage biopharmaceutical company committed to the research and development of immune system disease treatments using small molecules and stem cell technology. The company is headquartered in Fairlawn, Ohio. The company went IPO on 2005-01-11. The Company’s business is engaged in bringing treatments.
SCAL stock price ended at $0 on 木曜日, after rising NaN%
On the latest trading day Apr 09, 2026, the stock price of SCAL rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of -- shares were traded, equating to a market value of approximately --.